Skip to main content

ADVERTISEMENT

Poster

Idiopathic hypersomnia (IH) is a rare neurologic disorder characterized by excessive daytime sleepiness, sleep inertia, long and unrefreshing sleep/naps, and cognitive dysfunction. Sympho...
10/26/2023
This study used qualitative interviews to understand the patient experience of narcolepsy (types 1[NT1]=12 and 2 [NT2]=10). Many participants received a narcolepsy diagnosis at least 10 y...
10/26/2023
This poster discusses results of a survey sent to consult liason psychiatrists regarding their views on consults regarding maternal capacity to care for a newborn. Our results showed diff...
10/26/2023
A cost-offset analysis of the long-acting injectable formulation of aripiprazole monohydrate to evaluate the direct medical costs associated with an increase in time to first hospitalizat...
10/26/2023
Work productivity loss (WPL) outcomes were compared among patients with treatment-resistant depression randomized to esketamine nasal spray (ESK) versus quetiapine extended-release (QUE) ...
10/26/2023
This case illustrates an atypical presentation of catatonia secondary to SC ingestion, with catatonia developing multiple days after ingestion and pre-empted by waxing and waning mental s...
10/26/2023
It's a rare clinical case of delusional parasitosis in adult male with drug resistansy and almost complete recovery under the influence of ECT and atypical neurological complications duri...
10/26/2023
KarXT, a combination of xanomeline (dual M1/M4 muscarinic receptor agonist) and trospium (peripherally restricted muscarinic receptor antagonist), showed promising results in the EMERGENT...
10/26/2023
Centanafadine (CTN) is a norepinephrine/dopamine/serotonin reuptake inhibitor being investigated for the treatment of attention-deficit/hyperactivity disorder (ADHD). Secondary efficacy o...
10/26/2023
This analysis of 2 pooled, 6-week, placebo-controlled monotherapy studies; a 6-month open-label extension (OLE) monotherapy study; and a 6-week, placebo-controlled adjunctive study evalua...
10/26/2023